The World Orphan Drug Congress USA 2026 is a leading global conference dedicated to advancing rare disease therapies and orphan drug development. Organized by Terrapinn, the event brings together pharmaceutical and biotechnology companies, regulatory bodies, payers, investors, and patient advocacy groups to collaborate on accelerating innovation and improving patient outcomes in rare disease treatment.
Hosted in Boston’s Seaport District, the event features extensive educational sessions, expert-led panels, and a dynamic exhibition showcasing cutting-edge technologies and solutions. With participation from global stakeholders, the congress serves as a critical platform for discussing regulatory pathways, clinical development challenges, market access strategies, and the integration of AI and real-world evidence in rare disease research.
Providers of arcade machines, immersive attractions, and entertainment systems designed for family entertainment centers and amusement venues.
Companies offering digital payment systems, card-based solutions, and revenue analytics platforms for seamless transaction management.
Specialists in venue planning, attraction layout, and customer experience optimization for entertainment spaces.
Providers of performance tracking tools, staffing systems, and automation platforms for efficient venue operations.
Suppliers of kiosks, redemption machines, ticketing systems, and prize management solutions.
Companies delivering risk management, leasing, consulting, and maintenance services to amusement businesses.
Decision-makers responsible for managing and expanding entertainment venues and attractions.
Professionals overseeing multiple amusement locations and operational performance.
Industry suppliers building partnerships and expanding distribution networks.
Leaders evaluating investment opportunities across the amusement and leisure sectors.
Teams focused on improving customer engagement, operational efficiency, and profitability.
Innovators exploring next-generation gaming, AI, and immersive entertainment solutions.
Reach professionals actively involved in orphan drug development and rare disease innovation.
All records are validated to ensure reliable outreach and campaign performance.
Connect with executives responsible for R&D, regulatory strategy, and commercialization.
Receive structured datasets optimized for CRM and marketing automation platforms.
Engage prospects before the event and follow up after key discussions and meetings.
Data aligned with GDPR and CAN-SPAM regulations for secure outreach.
Access past and upcoming event editions with verified attendee and exhibitor email lists. Get accurate contact details of event attendees, key decision-makers, and exhibiting companies to power targeted B2B outreach and lead generation.





Our process is designed to deliver accurate, event-specific contact data while maintaining quality, relevance, and compliance at every stage.
We collect contact information exclusively from real expos, trade shows, conferences, and business events using trusted online and offline sources. This ensures our databases are built around active, relevant audiences, not generic or unrelated records.
Once data is collected, missing or incomplete fields are appended to create detailed and usable contact profiles. This includes company details, job roles, industry information, and event relevance to support targeted outreach.
Every contact record goes through validation checks to improve accuracy and reduce outdated or invalid information. Our review process helps ensure better data quality and improved campaign performance.
Target contacts by specific events, industries, job roles, company size, or locations for focused and effective outreach.
Connect with global pharma and biotech decision-makers shaping orphan drug innovation.
Reach teams focused on pricing, reimbursement, and global access strategies.
Engage organizations actively seeking collaborations and research partnerships.
Target stakeholders involved in clinical development and patient engagement.
Expand visibility within rare disease and precision medicine communities.
Convert high-intent event professionals into qualified leads and long-term clients.
Request curated attendee and exhibitor data from top global trade shows, verified, updated, and ready for targeted outreach.
Click HereThe event covers pharmaceuticals, biotechnology, regulatory affairs, and rare disease research sectors.
Yes, it includes verified contacts from both attendees and exhibiting organizations.
The data is provided in Excel or CSV formats compatible with CRM systems.